著者: AdamZ, ŘehákZ, AdamováZ, PourL, DvořákováK, PackováB, KoukalováR, KrejčíMartin, KrejčíMarta, ŠtorkM, SandeckáV, BoichukI, KrálZ

原題: Slow increase of bilirubin concentration during administration of lenalidomide, bortezomib and dexamethasone for multiple myeloma (unmasking previously undiagnosed Gilbert syndrome) and disappearance of necrobiotic xanthogranuloma after complete remission of multiple myeloma.

著者: SunJing, MaXiao-Shan, QuLi-Mei, SongXue-Song

原題: Subcutaneous panniculitis-like T-cell lymphoma invading central nervous system in long-term clinical remission with lenalidomide: A case report.

著者: van de DonkNiels Wcj, van der HoltBronno, MinnemaMonique C, VellengaEdo, CroockewitSandra, KerstenMarie José, von dem BornePeter A, YpmaPaula, SchaafsmaRon, de WeerdtOkke, KleinSaskia K, DelforgeMichel, LevinMark-David, BosGerard M, JieKon-Siong G, SinnigeHarm, CoenenJules Llm, de WaalEsther G, ZweegmanSonja, SonneveldPieter, LokhorstHenk M

原題: Thalidomide before and after autologous stem cell transplantation in recently diagnosed multiple myeloma (HOVON-50): long-term results from the phase 3, randomised controlled trial.

著者: ZelmatYoann, DespasFabien

原題: Drug-induced tumoral disease: A global pharmacovigilance database analysis.

著者: MushtaqAdeela, KapoorVikas, LatifAzka, IftikharAhmad, ZahidUmar, McBrideAli, AbrahamIvo, RiazIrbaz Bin, AnwerFaiz

原題: Efficacy and toxicity profile of carfilzomib based regimens for treatment of multiple myeloma: A systematic review.

著者: BonnetAntoine, MoreauPhilippe

原題: Safety of ixazomib for the treatment of multiple myeloma.

著者: LiXian, WangWeiqin, ZhangXiaohong, LiangYun

原題: Multiple myeloma with isolated central nervous system relapse after autologous stem cell transplantation: A case report and review of the literature.

著者: CrawfordLisa J, CampbellDavid C, MorganJonathan J, LawsonMichelle A, DownJennifer M, ChauhanDharminder, McAveraRoisin M, MorrisTreen C, HamiltonClaudia, KrishnanAswini, RajalingamKrishnaraj, ChantryAndrew D, IrvineAlexandra E

原題: The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.

著者: MontastrucJean-Louis, LafaurieMargaux, de CanecaudeClaire, DurrieuGeneviève, SommetAgnès, MontastrucFrançois, BagheriHaleh

原題: Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.

著者: TangSishi, ChengBingqing, ZheNana, MaDan, XuJibing, LiXinyao, GuoYongling, WuWeibing, WangJishi

原題: Histone deacetylase inhibitor BG45-mediated HO-1 expression induces apoptosis of multiple myeloma cells by the JAK2/STAT3 pathway.

著者: PatriziAnnalisa, VenturiMichela, DikaEmi, MaibachHoward, TacchettiPaola, BrandiGiovanni

原題: Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects.

著者: RichardsonPaul G, JacobusSusanna J, WellerEdie A, HassounHani, LonialSagar, RajeNoopur S, MedvedovaEva, McCarthyPhilip L, LibbyEdward N, VoorheesPeter M, OrlowskiRobert Z, AndersonLarry D, ZonderJeffrey A, MilnerCarter P, GasparettoCristina, AghaMounzer E, KhanAbdullah M, HurdDavid D, GowinKrisstina, KambleRammurti T, JagannathSundar, NathwaniNitya, AlsinaMelissa, CornellR Frank, HashmiHamza, CampagnaroErica L, AndreescuAstrid C, GentileTeresa, LiedtkeMichaela, GodbyKelly N, CohenAdam D, OpenshawThomas H, PasquiniMarcelo C, GiraltSergio A, KaufmanJonathan L, YeeAndrew J, ScottEmma, TorkaPallawi, FoleyAmy, FulcinitiMariateresa, HebertKyle, SamurMehmet K, MasoneKelly, MaglioMichelle E, ZeytoonjianAndrea A, NadeemOmar, SchlossmanRobert L, LaubachJacob P, Paba-PradaClaudia, GhobrialIrene M, PerrotAurore, MoreauPhilippe, Avet-LoiseauHervé, AttalMichel, AndersonKenneth C, MunshiNikhil C,

原題: Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.

著者: Moreland-HeadLindsay N, CoonsJames C, SeybertAmy L, GrayMatthew P, Kane-GillSandra L

原題: Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.

著者: JangHa Young, LeeHyun Kyung, KimChae Jeong, YoonSung-Soo, KimIn-Wha, OhJung Mi

原題: Carfilzomib's Real-World Safety Outcomes in Korea: Target Trial Emulation Study Using Electronic Health Records.

著者: WangXin, VogtBennett, ShanahanLindsey, SiddiquiA Daniyal, Subramonia-IyerSubramony, KhananiSaleem, BednarikJayde L, MittalKriti, RamanathanMuthalagu, GerberJonathan M, CernyJan

原題: Elotuzumab-based maintenance therapy following autologous stem cell transplant in multiple myeloma deepens post-transplant responses.

著者: ZhouLiang, XuGuoqiang

原題: The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases.

著者: FornasierG, TaborelliM, FrancesconS, PoleselJ, AlibertiM, De PaoliP, BaldoP

原題: Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance.

著者: CharlińskiGrzegorz, VesoleDavid H, JurczyszynArtur

原題: Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma.

著者: SugiTomiyuki, MitaMitsuo, YasuTakeo, OharaShin, UchidaTomoyuki, InoueMorihiro, HagiharaMasao

原題: Simple desensitization protocol for multiple myeloma patients with lenalidomide-induced skin rash: Case series.

著者: SatoJunya, ErenTsuchiya, MurataSaeko, ShimizuTadashi, UchidaMayako

原題: Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database.

著者: IacoboniG, ZuccaE, GhielminiM, StathisA

原題: Methodology of clinical trials evaluating the incorporation of new drugs in the first-line treatment of patients with diffuse large B-cell lymphoma (DLBCL): a critical review.

著者: FranzJoseph, MyrusElizabeth, SanchezLarysa, RichterJoshua

原題: No needles needed: All-oral therapy options for relapsed and refractory multiple myeloma.

著者: EgleAlexander, SteurerMichael, MelchardtThomas, WeissLukas, GassnerFranz Josef, ZaborskyNadja, GeisbergerRoland, CatakovicKemal, HartmannTanja Nicole, PleyerLisa, VoskovaDaniela, ThalerJosef, LangAlois, GirschikofskyMichael, PetzerAndreas, GreilRichard

原題: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.

著者: FenkRoland, GiagounidisAristoteles, GoldschmidtHartmut, HeinschMichael, RummelMathias, KrogerNicolaus, BoquoiAmelie, LopezDavid, GerrlichCelina, BaierJulia, LiesenjohannSvenja, HauckKatarzyna, SavickaiteIngrida, MaiElias K, AulCarlo, StrapatsasJudith, DienstAriane, KondakciMustafa, HaasRainer, KobbeGuido

原題: Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation.